Interleukin-17 in human inflammatory diseases

Postepy Dermatologii i Alergologii

Volumn 31, Issue 4, 2014, Pages 256-261

  Shabgah, Arezoo Gowhari ^a   Fattahi, Ebrahim ^b   Shahneh, Fatemeh Zare ^c,d  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c MAX PLANCK INSTITUTE FOR CHEMISTRY   (Germany)

^d JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

Autoimmunity; Cytokine receptors; Cytokines; Inflammation; Interleukin 17; T cells

Indexed keywords

INTERLEUKIN 17; INTERLEUKIN 17 RECEPTOR;

ADAPTIVE IMMUNITY; AUTOIMMUNE DISEASE; AUTOIMMUNITY; BEHCET DISEASE; BIOLOGICAL FUNCTIONS; CELL DIFFERENTIATION; CELL MIGRATION; CHRONIC INFLAMMATION; CROHN DISEASE; CYTOKINE RELEASE; ENDOTHELIUM; EPITHELIUM; FIBROBLAST; HOST RESISTANCE; HUMAN; HYPER IGE SYNDROME; IMMUNOREGULATION; INFLAMMATORY BOWEL DISEASE; INFLAMMATORY DISEASE; INNATE IMMUNITY; MULTIPLE SCLEROSIS; NONHUMAN; PROTEIN EXPRESSION; PSORIASIS; REVIEW; RHEUMATOID ARTHRITIS; SIGNAL TRANSDUCTION; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS; T LYMPHOCYTE; TH17 CELL; TISSUE INJURY;

EID: 84907030017     PISSN: 1642395X     EISSN: None     Source Type: Journal    
DOI: 10.5114/pdia.2014.40954     Document Type: Review

References (61)

1. Basu R, Hatton RD, Weaver CT. The Th17 family: flexibility follows function. Immunol Rev 2013; 252: 89-103.
2. Miossec P, Kolls JK. Targeting IL-17 and Th17 cells in chronic inflammation. Nat Rev Drug Dis 2012; 11: 763-76.
3. Fujimura K, Oyamada A, Iwamoto Y, et al. CD4 T cell-intrinsic IL-2 signaling differentially affects Th1 and Th17 development. J Leukoc Biol 2013; 94: 271-9.
4. Kolls J. The role of Th17 cytokines in primary mucosal immunity. Cyt Gro Fact Rev 2010; 21: 443-8.
5. Matsuzaki G, Umemura M. Interleukin-17 as an effector molecule of innate and acquired immunity against infections. Microbiol Immunol 2007; 51: 1139-47.
6. Zhi Chen, O'Shea J. Th17 cells: a new fate for differentiating helper T cells. Immunol Res 2008; 41: 87-102.
7. Awasthi A, Kuchroo V. Th17 cells: from precursors to players in inflammation and infection. Interl Immunol 2009; 21: 489-98.
8. Zúńiga LA, Jain R, Haines C, Cua DJ. Th17 cell development: from the cradle to the grave. Immunol Rev 2013; 252: 78-88.
9. Maddur MS, Miossec P, Kaveri SV, Bayry J. Th17 cells: biology, pathogenesis of autoimmune and inflammatory diseases, and therapeutic strategies. Am J Pathol 2012; 181: 8-18.
10. Korn T, Bettelli E, Oukka M. IL-17 and Th17 cells. Annul Rev Immunol 2009; 27: 485-517.
11. Bettelli E, Korn T, Kuchroo V. Th17: the third member of the effector T cell Trilogy. Curr Opin Immunol 2007; 19: 652-7.
12. Gaffen S. Structure and signaling in the IL-17 receptor superfamily. Nat Rev Immunol 2009; 9: 1-24.
13. Tsai HC, Velichko S, Hung LY, Wu R. IL-17A and Th17 cells in lung inflammation: an update on the role of Th17 cell differentiation and IL-17R signaling in host defense against infection. Clin Dev Immunol 2013; 2013: 267971.
14. Fouser L. Th17 cytokines and their emerging roles in inflammation and autoimmunity. Immunol Rev 2008; 226: 87-102.
15. Wilson NJ. Development, cytokine profile and function of human interleukin 17-producing helper T cells. Nat Immunol 2007; 8: 950-7.
16. Acosta-Rodriguez EV, Napolitani G. Interleukins 1beta and 6 but not transforming growth factor-beta is essential for the differentiation of interleukin 17-producing human T helper cells. Nat Immunol 2007; 8: 942-9.
17. Ivaylo I, Ivanov A, Liang Zhoua. Transcriptional regulation of Th17 cell differentiation. Sem Immunol 2007; 19: 409-17.
18. O'Connor RA, Cambrook H, Huettner K, Anderton SM. T-bet is essential for Th1-mediated, but not Th17-mediated, CNS autoimmune disease. Eur J Immunol 2013; 43: 2818-23.
19. Yang XO. STAT3 regulates cytokine-mediated generation of inflammatory helper T cells. J Biol Chem 2007; 282: 9358-63.
20. McGeachy M, Daniel J. Th17 Cell differentiation: the long and winding road. Immunity 2008; 28: 445-53.
21. Korn T. Th17 cells: effector T cells with inflammatory properties. Sem Immunol 2007; 19: 362-71.
22. Chang S, Dong C. Signaling of interleukin-17 family cytokines in immunity and inflammation. Cell Sign 2011; 23: 1069-75.
23. Hisakata Y. Current perspectives on the role of IL-17 in autoimmune disease. J Inflam Res 2010; 3: 33-44.
24. Korn T. IL-21 initiates an alternative pathway to induce proinflammatory TH17 cells. Nature 2007; 448: 484-7.
25. Nurieva R. Essential autocrine regulation by IL-21 in the generation of inflammatory T cells. Nature 2007; 448: 480-3.
26. Zheng Y. Interleukin-22, a Th17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis. Nature 2007; 445: 648-51.
27. Rutz S, Eidenschenk C, Ouyang W. IL-22, not simply a Th17 cytokine. Immunol Rev 2013; 252: 116-32.
28. Becher B, Segal BM. Th17 cytokines in autoimmune neuro-inflammation. Curr Opin Immunol 2011; 23: 707-12.
29. Oh H, Ghosh S. NF-kappaB: roles and regulation in different CD4 (+) T-cell subsets. Immunol Rev 2013; 252: 41-51.
30. De Jong E, Suddason T, Lord G. M. Translational mini-review series on Th17 cells: induction of interleukin-17 production by regulatory T cells. Clin Exp Immunol 2009; 159: 109-19.
31. Louten J, Boniface K, Waal Malefyt R. Development and function of TH17 cells in health and disease. J Allergy Clin Immunol 2009; 123: 1004-11.
32. Muranski P, Restifo NP. Essentials of Th17 cell commitment and plasticity. Blood 2013; 121: 2402-14.
33. Tesmer M. Th17 cells in human disease. Immunol Rev 2008; 223: 87-113.
34. Li N, Wang JC, Liang TH, et al. Pathologic finding of increased expression of interleukin-17 in the synovial tissue of rheumatoid arthritis patients. Int J Clin Exp Pathol 2013; 6: 1375-9.
35. Iwakura Y. The roles of IL-17A in inflammatory immune responses and host defense against pathogens. Immunol Rev 2008; 226: 57-79.
36. Azizi G, Jadidi-Niaragh F, Mirshafiey A. Th17 cells in immunopathogenesis and treatment of rheumatoid arthritis. Int J Rheum Dis 2013; 16: 243-53.
37. Truchetet ME, Mossalayi MD, Boniface K. IL -17 in the rheumatologist's line of sight. Biomed Res Int 2013; 2013: 295132. doi: 10.1155/2013/295132
38. Raychaudhuri SP. Role of IL-17 in psoriasis and psoriatic arthritis. Clin Rev Allergy Immunol 2013; 44: 183-93.
39. Arican O, Sasmaz S, Ciragil P. Serum levels of TNF-alpha, IFN-gamma, IL-6, IL-8, IL-12, IL-17, and IL-18 in patients with active psoriasis and correlation with disease severity. Mediators Inflamm 2005; 200: 273-9.
40. Perry D. The current concept of Th17 cells and their expanding role in systemic lupus erythematous. Arthritis 2011; 49: 1-10.
41. Zhao L, Jiang Z, Jiang Y, et al. IL-22+CD4+ T-cells in patients with active systemic lupus erythematosus. Exp Biol Med (Maywood) 2013; 238: 193-9.
42. Pernis B. Th17 cells in rheumatoid arthritis and systemic lupus erythematous. J Internal Med 2009; 265: 644-52.
43. Li L, Boussiotis VA. The role of IL-17-producing Foxp3 (+) CD4 (+) T cells in inflammatory bowel disease and colon cancer. Clin Immunol 2013; 148: 246-53.
44. Dige A, Støy S, Rasmussen TK, et al. Increased levels of circulating Th17 cells in quiescent versus active Crohn's disease. J Crohns Colitis 2013; 7: 248-55.
45. Siakavellas SI, Bamias G. Role of the IL-23/IL-17 axis in Crohn's disease. Discov Med 2012; 14: 253-62.
46. Brembilla NC, Chizzolini C. T cell abnormalities in systemic sclerosis with a focus on Th17 cells. Eur Cytokine Netw 2012; 23: 128-39.
47. Zepp J, Wu L, Li X. IL-17 receptor signaling and T helper 17-mediated autoimmune demyelinating disease. Trends Immunol 2011; 32: 232-9.
48. Aranami T, Yamamura T. Th17 cells and autoimmune encephalomyelitis (EAE/MS). Allergol Inter 2008; 57: 115-20.
49. Takehara K, Sato S. Localized scleroderma is an auto immune disorder. Rheumatology 2005; 44: 274-9.
50. Onishi RM, Gaffen SL. Interleukin-17 and its target genes: mechanisms of interleukin-17 function in disease. Immunology 2010; 129: 311-21.
51. Dańczak-Pazdrowska A, Kowalczyk M, Szramka-Pawlak B, et al. Interleukin-17A and interleukin-23 in morphea. Arch Med Sci 2012; 8: 1089-95.
52. Kurasawa K, Hirose K, Sano H, et al. Increased interleukin 17 production in patients with systemic sclerosis. Arthritis Rheum 2000; 43: 2455-63.
53. Deleuran B, Abraham D. Possible implication of the effector CD4+ T-cell subpopulation TH17 in the pathogenesis of systemic scleroderma. Nat Clin Pract Rheumatol 2007; 3: 682-3.
54. Nakashima T, Masatoshi J, Keitaro Y, et al. Impaired IL-17 signaling pathway contributes to the increased collagen expression in scleroderma fibroblasts. J Immunol 2012; 188: 3573-83.
55. von Vietinghoff S, Ley K. Interleukin 17 in vascular inflammation. Cytokine Growth Factor Rev 2010; 21: 463-9.
56. Shahneh FZ, Babaloo Z, Baradaran B, et al. Behçet's syndrome in Iranian Azari people. Pak J Biol Sci 2012; 15: 1045-7.
57. Shahneh FZ, Babaloo Z, Baradaran B, Sepehr KS. Insights into Behçet's disease. Postep Derm Alergol 2012; 29: 461-6.
58. Shahneh FZ, Babaloo Z, Baradaran B, et al. New insights of HLA class I association to Behçet's syndrome in Iranian Azari patients. Autoimmunity Highlight 2013; 4: 101-2.
59. Geri G, Terrier B, Rosenzwajg M. Critical role of IL-21 in modulating Th17 and regulatory T cells in Behcet disease. J Aller Clin Immunol 2011; 128: 655-64.
60. Schuijs MJ, Willart MA, Hammad H, Lambrecht BN. Cytokine targets in airway inflammation. Curr Opin Pharmacol 2013; 13: 351-61.
61. Ma CS, Chew GY, Simpson N. Deficiency of Th17 cells in hyper IgE syndrome due to mutation in STAT3. J Exp Med 2008; 205: 1551-7.